Applied Genetic Technologies Corporation
AGTC · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $34,674 | $128,076 | $116,905 | $67,181 |
| - Cash | $46,366 | $105,052 | $38,463 | $26,703 |
| + Debt | $22,471 | $24,480 | $10,783 | $0 |
| Enterprise Value | $10,779 | $47,504 | $89,225 | $40,478 |
| Revenue | $325 | $500 | $2,453 | $41,692 |
| % Growth | -35% | -79.6% | -94.1% | – |
| Gross Profit | $325 | $500 | $2,453 | $41,692 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$64,757 | -$56,971 | -$46,942 | -$4,350 |
| % Margin | -19,925.2% | -11,394.2% | -1,913.7% | -10.4% |
| Net Income | -$71,424 | -$57,829 | -$45,892 | -$2,006 |
| % Margin | -21,976.6% | -11,565.8% | -1,870.9% | -4.8% |
| EPS Diluted | -1.59 | -1.77 | -2.17 | -0.11 |
| % Growth | 10.2% | 18.4% | -1,872.7% | – |
| Operating Cash Flow | -$65,748 | -$51,173 | -$41,620 | -$23,457 |
| Capital Expenditures | -$2,014 | -$1,861 | -$1,197 | -$311 |
| Free Cash Flow | -$67,762 | -$53,034 | -$42,817 | -$23,768 |